The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
The Role of Nrf2 Activity in Cancer Development and Progression
Open accessAbstract
Nrf2 is a transcription factor that stimulates the expression of genes which have antioxidant response element-like sequences in their promoter. Nrf2 is a cellular protector, and this principle applies to both normal cells and malignant cells. While healthy cells are protected from DNA damage induced by reactive oxygen species, malignant cells are defended against chemo- or radiotherapy. Through our literature search, we found that Nrf2 activates several oncogenes unrelated to the antioxidant activity, such as Matrix metallopeptidase 9 (MMP-9), B-cell lymphoma 2 (BCL-2), B-cell lymphoma-extra large (BCL-xL), Tumour Necrosis Factor α (TNF-α), and Vascular endothelial growth factor A (VEGF-A). We also did a brief analysis of The Cancer Genome Atlas (TCGA) data of lung adenocarcinoma concerning the effects of radiation therapy and found that the therapy-induced Nrf2 activation is not universal. For instance, in the case of recurrent disease and radiotherapy, we observed that, for the majority of Nrf2-targeted genes, there is no change in expression level. This proves that the universal, axiomatic rationale that Nrf2 is activated as a response to chemo- and radiation therapy is wrong, and that each scenario should be carefully evaluated with the help of Nrf2-targeted genes. Moreover, there were nine genes involved in lipid peroxidation, which showed underexpression in the case of new radiation therapy: ADH1A, ALDH3A1, ALDH3A2, ADH1B, GPX2, ADH1C, ALDH6A1, AKR1C3, and NQO1. This may relate to the fact that, while some studies reported the co-activation of Nrf2 and other oncogenic signaling pathways such as Phosphoinositide 3-kinases (PI3K), mitogen-activated protein kinase (MAPK), and Notch1, other reported the inverse correlation between Nrf2 and the tumor-promoter Transcription Factor (TF), Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB). Lastly, Nrf2 establishes its activity through interactions at multiple levels with various microRNAs. MiR-155, miR-144, miR-28, miR-365-1, miR-93, miR-153, miR-27a, miR-142, miR-29-b1, miR-340, and miR-34a, either through direct repression of Nrf2 messenger RNA (mRNA) in a Kelch-like ECH-associated protein 1 (Keap1)-independent manner or by enhancing the Keap1 cellular level, inhibit the Nrf2 activity. Keap1–Nrf2 interaction leads to the repression of miR-181c, which is involved in the Nuclear factor kappa light chain enhancer of activated B cells (NF-κB) signaling pathway. Nrf2’s role in cancer prevention, diagnosis, prognosis, and therapy is still in its infancy, and the future strategic planning of Nrf2-based oncological approaches should also consider the complex interaction between Nrf2 and its various activators and inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Khatri, R., Shah, P., Guha, R., Rassool, F. V., Tomkinson, A. E., Brodie, A. M. H., & Jaiswal, A. K. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0672 · Cited by 17
RetractedSzklarczyk, D., Gable, A. L., Lyon, D., Junge, A., Wyder, S., Huerta-Cepas, J., Simonovic, M., Doncheva, N. T., Morris, J. H., Bork, P., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1131 · Cited by 17,749
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Tang, Z., Li, C., Kang, B., Gao, G., Li, C., & Zhang, Z. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx247 · Cited by 9,849
Targeting the KEAP1-NRF2 system to prevent kidney disease progression
Nezu, M., Suzuki, N., & Yamamoto, M. (2017) · American Journal of Nephrology · doi:10.1159/000475890 · Cited by 3,447
The complexity of NF-κB signaling in inflammation and cancer
Hoesel, B., & Schmid, J. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-86 · Cited by 3,165
Komatsu, M., Kurokawa, H., Waguri, S., Taguchi, K., Kobayashi, A., Ichimura, Y., Sou, Y.-S., Ueno, I., Sakamoto, A., Tong, K. I., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2021 · Cited by 2,288
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
DeNicola, G. M., Karreth, F. A., Humpton, T. J., Gopinathan, A., Wei, C., Frese, K., Mangal, D., Yu, K. H., Yeo, C. J., Calhoun, E. S., et al. (2011) · Nature · doi:10.1038/nature10189 · Cited by 2,277
The Nrf2 regulatory network provides an interface between redox and intermediary metabolism
Hayes, J. D., & Dinkova-Kostova, A. T. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.002 · Cited by 2,141
Nrf2 signaling pathway: pivotal roles in inflammation
Ahmed, S. M. U., Luo, L., Namani, A., Wang, X. J., & Tang, X. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.005 · Cited by 1,794
Moi, P., Chan, K., Asunis, I., Cao, A., & Kan, Y. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9926 · Cited by 1,607 · cited 1×
“The NFE2L2 gene encodes the Nrf2 protein [7], which is part of the “Cap ’n’ Collar” (CNC) family of transcription factors (TFs) [8].”
BackgroundJain, A., Lamark, T., Sjøttem, E., Bowitz Larsen, K., Atesoh Awuh, J., Øvervatn, A., McMahon, M., Hayes, J. D., & Johansen, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.118976 · Cited by 1,472
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
Mitsuishi, Y., Taguchi, K., Kawatani, Y., Shibata, T., Nukiwa, T., Aburatani, H., Yamamoto, M., & Motohashi, H. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.016 · Cited by 1,395 · cited 2×
“It was proven that the overexpression of Nrf2 leads to changes in the cell metabolism; for instance, it changes anabolism [68], or it inhibits lipogenesis and simulates the β-oxidation of fatty acids [69].”
BackgroundThe Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer
Kansanen, E., Kuosmanen, S. M., Leinonen, H., & Levonen, A.-L. (2013) · Redox Biology · doi:10.1016/j.redox.2012.10.001 · Cited by 1,313 · cited 2×
“In some cancer types, one or both Keap1 and Nrf2 are mutated, which does not allow a proper chemical interaction between the two [22,31–33].”
BackgroundThe emerging role of the Nrf2–Keap1 signaling pathway in cancer
Jaramillo, M. C., & Zhang, D. D. (2013) · Genes & Development · doi:10.1101/gad.225680.113 · Cited by 1,297
PI3K-Akt pathway: Its functions and alterations in human cancer
Osaki, M., Oshimura, M., & Ito, H. (2004) · Apoptosis · doi:10.1023/b:appt.0000045801.15585.dd · Cited by 1,264
Nrf2 Is a Direct PERK Substrate and Effector of PERK-Dependent Cell Survival
Cullinan, S. B., Zhang, D., Hannink, M., Arvisais, E., Kaufman, R. J., & Diehl, J. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.20.7198-7209.2003 · Cited by 1,234
NF-κB, an Active Player in Human Cancers
Xia, Y., Shen, S., & Verma, I. M. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0112 · Cited by 1,213
Phosphorylation of p62 Activates the Keap1-Nrf2 Pathway during Selective Autophagy
Ichimura, Y., Waguri, S., Sou, Y.-S., Kageyama, S., Hasegawa, J., Ishimura, R., Saito, T., Yang, Y., Kouno, T., Fukutomi, T., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.003 · Cited by 1,205
Dissecting molecular cross-talk between Nrf2 and NF-κB response pathways
Wardyn, J. D., Ponsford, A. H., & Sanderson, C. M. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150014 · Cited by 1,200 · cited 1×
“Nuclear factor kappa light chain enhancer of activated B cells (NF-κB) ↓ Nrf2 ↑ NF-κB Enhanced Inhibitor of nuclear factor kappa-B kinase subunit beta (IKKβ) activity, degradation of nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (IκBα) [122]”
BackgroundChang, F., Lee, J. T., Navolanic, P. M., Steelman, L. S., Shelton, J. G., Blalock, W. L., Franklin, R. A., & McCubrey, J. A. (2003) · Leukemia · doi:10.1038/sj.leu.2402824 · Cited by 1,176
NRF2 and cancer: the good, the bad and the importance of context
Sporn, M. B., & Liby, K. T. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3278 · Cited by 1,067 · cited 1×
“Nrf2 protects both normal and cancerous cells from oxidative damage, meaning that it inhibits malignant transformation; however, once cancer is installed, it offers resistance to therapy [28] (Figure 1).”
BackgroundTebay, L. E., Robertson, H., Durant, S. T., Vitale, S. R., Penning, T. M., Dinkova-Kostova, A. T., & Hayes, J. D. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.021 · Cited by 837 · cited 5×
“The cancer stem cells gain radioresistance by activating DNA repair mechanisms, diminishing ROS level with the help of stimulated glutathione biosynthesis, activating anti-apoptotic pathways, and decreasing the intratumoral hypoxia [160].”
BackgroundInfluentialStress-activated cap’n’collar transcription factors in aging and human disease
Sykiotis, G. P., & Bohmann, D. (2010) · Science Signaling · doi:10.1126/scisignal.3112re3 · Cited by 776 · cited 1×
“The NFE2L2 gene encodes the Nrf2 protein [7], which is part of the “Cap ’n’ Collar” (CNC) family of transcription factors (TFs) [8].”
BackgroundMicroRNAs as Oncogenes and Tumor Suppressors
Chen, C.-Z. (2005) · New England Journal of Medicine · doi:10.1056/nejmp058190 · Cited by 758
NRF2 regulates serine biosynthesis in non–small cell lung cancer
DeNicola, G. M., Chen, P.-H., Mullarky, E., Sudderth, J. A., Hu, Z., Wu, D., Tang, H., Xie, Y., Asara, J. M., Huffman, K. E., et al. (2015) · Nature Genetics · doi:10.1038/ng.3421 · Cited by 746
Maj, T., Wang, W., Crespo, J., Zhang, H., Wang, W., Wei, S., Zhao, L., Vatan, L., Shao, I., Szeliga, W., et al. (2017) · Nature Immunology · doi:10.1038/ni.3868 · Cited by 733 · cited 1×
“Nrf2 antioxidant activity is involved in regulatory T cells (T regs) apoptosis, which counteracts the beneficial role of Programmed cell death 1 ligand 1 (PD-L1) antitumor therapy [59].”
BackgroundShibata, T., Ohta, T., Tong, K. I., Kokubu, A., Odogawa, R., Tsuta, K., Asamura, H., Yamamoto, M., & Hirohashi, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806268105 · Cited by 728
Liu, G.-H., Qu, J., & Shen, X. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.002 · Cited by 697 · cited 2×
“P65 overexpression is induced by NF-κB signaling [115].”
BackgroundNrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis
Fan, Z., Wirth, A.-K., Chen, D., Wruck, C. J., Rauh, M., Buchfelder, M., & Savaskan, N. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.65 · Cited by 692
p62 links autophagy and Nrf2 signaling
Jiang, T., Harder, B., Rojo de la Vega, M., Wong, P. K., Chapman, E., & Zhang, D. D. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.014 · Cited by 639
Direct Interaction between Nrf2 and p21Cip1/WAF1 Upregulates the Nrf2-Mediated Antioxidant Response
Chen, W., Sun, Z., Wang, X.-J., Jiang, T., Huang, Z., Fang, D., & Zhang, D. D. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.04.029 · Cited by 638 · cited 1×
“P21 is a positive regulator of Nrf2, via direct interaction, which stabilizes the Nrf2 protein [13].”
BackgroundThe Dual Roles of NRF2 in Cancer
Menegon, S., Columbano, A., & Giordano, S. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.05.002 · Cited by 633 · cited 1×
“Nrf2 is a cytoprotective transcription factor which has both a positive effect and a negative effect on cancer [26,27].”
BackgroundStructural basis of Keap1 interactions with Nrf2
Canning, P., Sorrell, F. J., & Bullock, A. N. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.034 · Cited by 592
Adam, J., Hatipoglu, E., O'Flaherty, L., Ternette, N., Sahgal, N., Lockstone, H., Baban, D., Nye, E., Stamp, G. W., Wolhuter, K., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.006 · Cited by 585 · cited 1×
“Another mechanism is the accumulation of fumarate and the succination of cysteine in Keap1 protein, which abolishes its sensitivity to oxidative stress [38,39], or the increased level of p21 [40] and p62 [41] proteins, which inhibit the interaction between Keap1 and Nrf2 [31,42].”
BackgroundNrf2 Protein Up-regulates Antiapoptotic Protein Bcl-2 and Prevents Cellular Apoptosis
Niture, S. K., & Jaiswal, A. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.312694 · Cited by 545
The KEAP1–NRF2 System in Cancer
Taguchi, K., & Yamamoto, M. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00085 · Cited by 527
Nrf2 in cancers: A double‐edged sword
Wu, S., Lu, H., & Bai, Y. (2019) · Cancer Medicine · doi:10.1002/cam4.2101 · Cited by 465
NGL Viewer: a web application for molecular visualization
Rose, A. S., & Hildebrand, P. W. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv402 · Cited by 462
The complexity of the Nrf2 pathway: beyond the antioxidant response
Huang, Y., Li, W., Su, Z.-Y., & Kong, A.-N. T. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.08.001 · Cited by 445
Cancer stem cells and chemoresistance: The smartest survives the raid
Zhao, J. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.02.008 · Cited by 437
Phosphoinositide 3-Kinase/Akt Signaling and Redox Metabolism in Cancer
Koundouros, N., & Poulogiannis, G. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00160 · Cited by 415
KEAP1 E3 Ligase-Mediated Downregulation of NF-κB Signaling by Targeting IKKβ
Lee, D.-F., Kuo, H.-P., Liu, M., Chou, C.-K., Xia, W., Du, Y., Shen, J., Chen, C.-T., Huo, L., Hsu, M.-C., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.07.025 · Cited by 399 · cited 1×
“The Keap1 genomic locus is lost or mutated in cancer [114].”
BackgroundDeshmukh, P., Unni, S., Krishnappa, G., & Padmanabhan, B. (2017) · Biophysical Reviews · doi:10.1007/s12551-016-0244-4 · Cited by 398
Redox Regulation by Keap1 and Nrf2 Controls Intestinal Stem Cell Proliferation in Drosophila
Hochmuth, C. E., Biteau, B., Bohmann, D., & Jasper, H. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2010.12.006 · Cited by 362
Arlt, A., Sebens, S., Krebs, S., Geismann, C., Grossmann, M., Kruse, M.-L., Schreiber, S., & Schäfer, H. (2013) · Oncogene · doi:10.1038/onc.2012.493 · Cited by 330
Cuadrado, A., Martín-Moldes, Z., Ye, J., & Lastres-Becker, I. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.540633 · Cited by 320
Molecular Basis of Electrophilic and Oxidative Defense: Promises and Perils of Nrf2
Ma, Q., & He, X. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.004333 · Cited by 317
miR-200a Regulates Nrf2 Activation by Targeting Keap1 mRNA in Breast Cancer Cells
Eades, G., Yang, M., Yao, Y., Zhang, Y., & Zhou, Q. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.275495 · Cited by 305
Krause, M., Dubrovska, A., Linge, A., & Baumann, M. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.002 · Cited by 305
BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival
Gorrini, C., Baniasadi, P. S., Harris, I. S., Silvester, J., Inoue, S., Snow, B., Joshi, P. A., Wakeham, A., Molyneux, S. D., Martin, B., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121337 · Cited by 289
The Nrf2-antioxidant response element pathway: a target for regulating energy metabolism
Vomhof-DeKrey, E. E., & Picklo, M. J. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.03.005 · Cited by 283
MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism
Yang, M., Yao, Y., Eades, G., Zhang, Y., & Zhou, Q. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1604-1 · Cited by 280
Transketolase counteracts oxidative stress to drive cancer development
Xu, I. M.-J., Lai, R. K.-H., Lin, S.-H., Tse, A. P.-W., Chiu, D. K.-C., Koh, H.-Y., Law, C.-T., Wong, C.-M., Cai, Z., Wong, C. C.-L., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508779113 · Cited by 251
Multiple-to-Multiple Relationships between MicroRNAs and Target Genes in Gastric Cancer
Hashimoto, Y., Akiyama, Y., & Yuasa, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062589 · Cited by 234
Jiang, T., Tian, F., Zheng, H., Whitman, S. A., Lin, Y., Zhang, Z., Zhang, N., & Zhang, D. D. (2014) · Kidney International · doi:10.1038/ki.2013.343 · Cited by 231
Best, S. A., De Souza, D. P., Kersbergen, A., Policheni, A. N., Dayalan, S., Tull, D., Rathi, V., Gray, D. H., Ritchie, M. E., McConville, M. J., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.006 · Cited by 217
Ionizing Radiation Activates the Nrf2 Antioxidant Response
McDonald, J. T., Kim, K., Norris, A. J., Vlashi, E., Phillips, T. M., Lagadec, C., Della Donna, L., Ratikan, J., Szelag, H., Hlatky, L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0171 · Cited by 217
Nrf2 and NF-κB and Their Concerted Modulation in Cancer Pathogenesis and Progression
Bellezza, I., Mierla, A. L., & Minelli, A. (2010) · Cancers · doi:10.3390/cancers2020483 · Cited by 216
Nrf2 Protects Pancreatic β-Cells From Oxidative and Nitrosative Stress in Diabetic Model Mice
Yagishita, Y., Fukutomi, T., Sugawara, A., Kawamura, H., Takahashi, T., Pi, J., Uruno, A., & Yamamoto, M. (2014) · Diabetes · doi:10.2337/db13-0909 · Cited by 204
Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1
Na, H.-K., & Surh, Y.-J. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.10.819 · Cited by 202
The new era of nanotechnology, an alternative to change cancer treatment
Jurj, A., Braicu, C., Pop, L.-A., Tomuleasa, C., Gherman, C., & Berindan-Neagoe, I. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s142337 · Cited by 198
Self-citationMethylation of the KEAP1 gene promoter region in human colorectal cancer
Hanada, N., Takahata, T., Zhou, Q., Ye, X., Sun, R., Itoh, J., Ishiguro, A., Kijima, H., Mimura, J., Itoh, K., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-66 · Cited by 190
Ge, W., Zhao, K., Wang, X., Li, H., Yu, M., He, M., Xue, X., Zhu, Y., Zhang, C., Cheng, Y., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.09.008 · Cited by 188
Zhang, M., Zhang, C., Zhang, L., Yang, Q., Zhou, S., Wen, Q., & Wang, J. (2015) · BMC Cancer · doi:10.1186/s12885-015-1541-1 · Cited by 179
Truong Do, M., Gyun Kim, H., Ho Choi, J., & Gwang Jeong, H. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.010 · Cited by 172
Bai, X., Chen, Y., Hou, X., Huang, M., & Jin, J. (2016) · Drug Metabolism Reviews · doi:10.1080/03602532.2016.1197239 · Cited by 164
Dual roles of NRF2 in tumor prevention and progression: Possible implications in cancer treatment
Moon, E. J., & Giaccia, A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.11.009 · Cited by 160
Nrf2 Pathway Regulates Multidrug-Resistance-Associated Protein 1 in Small Cell Lung Cancer
Ji, L., Li, H., Gao, P., Shang, G., Zhang, D. D., Zhang, N., & Jiang, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063404 · Cited by 158
Kang, K. A., Piao, M. J., Kim, K. C., Kang, H. K., Chang, W. Y., Park, I. C., Keum, Y. S., Surh, Y. J., & Hyun, J. W. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.149 · Cited by 149
Digaleh, H., Kiaei, M., & Khodagholi, F. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1409-y · Cited by 148
Perspectives of the Nrf-2 signaling pathway in cancer progression and therapy
Basak, P., Sadhukhan, P., Sarkar, P., & Sil, P. C. (2017) · Toxicology Reports · doi:10.1016/j.toxrep.2017.06.002 · Cited by 146
NF-κB, Nrf2, and HO-1 Interplay in Redox-Regulated VCAM-1 Expression
Banning, A., & Brigelius‐Flohé, R. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.889 · Cited by 141
Nrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxia
Syu, J.-P., Chi, J., & Kung, H. (2016) · Oncotarget · doi:10.18632/oncotarget.7406 · Cited by 141
Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2
Tung, M., Lin, P.-L., Wang, Y.-C., He, T.-Y., Lee, M.-C., Yeh, S.-D., Chen, C., & Lee, H. (2015) · Oncotarget · doi:10.18632/oncotarget.6150 · Cited by 140
Modulation of NRF2 signaling pathway by nuclear receptors: Implications for cancer
Namani, A., Li, Y., Wang, X. J., & Tang, X. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.05.003 · Cited by 139
Cancer-Derived Mutations in KEAP1 Impair NRF2 Degradation but not Ubiquitination
Hast, B. E., Cloer, E. W., Goldfarb, D., Li, H., Siesser, P. F., Yan, F., Walter, V., Zheng, N., Hayes, D. N., & Major, M. B. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1655 · Cited by 138
Nrf2 protects mitochondrial decay by oxidative stress
Strom, J. G., Xu, B., Tian, X., & Chen, Q. M. (2015) · The FASEB Journal · doi:10.1096/fj.14-268904 · Cited by 137
Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in Pancreas
Todoric, J., Antonucci, L., Caro, G. D., Li, N., Wu, X., Lytle, N. K., Dhar, D., Banerjee, S., Fagman, J. B., Browne, C. D., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.10.011 · Cited by 136
Zhang, C., Wang, H.-J., Bao, Q., Wang, L., Guo, T.-K., Chen, W., Xu, L., Zhou, H.-S., Bian, J., Yang, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12435 · Cited by 133
Shi, L., Wu, L. J., Chen, Z., Yang, J., Chen, X., Yu, F., Zheng, F., & Lin, X. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000374036 · Cited by 126
Oxidative stress, mammospheres and Nrf2–new implication for breast cancer therapy?
Wu, T., Harder, B. G., Wong, P. K., Lang, J. E., & Zhang, D. D. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.22202 · Cited by 121
Chian, S., Li, Y., Wang, X. J., & Tang, X. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.6.2911 · Cited by 114
T Lymphocyte–Specific Activation of Nrf2 Protects from AKI
Noel, S., Martina, M. N., Bandapalle, S., Racusen, L. C., Potteti, H. R., Hamad, A. R. A., Reddy, S. P., & Rabb, H. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014100978 · Cited by 113
Kinch, L. N., Grishin, N. V., & Brugarolas, J. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.10.005 · Cited by 111
Dysregulation of NRF2 in Cancer: from Molecular Mechanisms to Therapeutic Opportunities
Jung, B.-J., Yoo, H.-S., Shin, S., Park, Y., & Jeon, S. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.195 · Cited by 108
ABCF2 , an Nrf2 target gene, contributes to cisplatin resistance in ovarian cancer cells
Bao, L., Wu, J., Dodson, M. B., de la Vega, E. M. R., Ning, Y., Zhang, Z., Yao, M., Zhang, D. D., Xu, C., & Yi, X. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22615 · Cited by 106
Negative Regulation of the Keap1-Nrf2 Pathway by a p62/Sqstm1 Splicing Variant
Kageyama, S., Saito, T., Obata, M., Koide, R.-H., Ichimura, Y., & Komatsu, M. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00642-17 · Cited by 105
Satoh, H., Moriguchi, T., Saigusa, D., Baird, L., Yu, L., Rokutan, H., Igarashi, K., Ebina, M., Shibata, T., & Yamamoto, M. P. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1584 · Cited by 104
A biphasic effect of TNF-α in regulation of the Keap1/Nrf2 pathway in cardiomyocytes
Shanmugam, G., Narasimhan, M., Sakthivel, R., Rajesh Kumar, R., Davidson, C. J., Sethu, P., Claycomb, W. C., Hoidal, J. R., Darley-Usmar, V. M., & Rajasekaran, N. S. (2016) · Redox Biology · doi:10.1016/j.redox.2016.06.004 · Cited by 103
Zhou, W., Mo, X., Cui, W., Zhang, Z., Li, D., Li, L., Xu, L., Yao, H., & Gao, J. (2016) · Scientific Reports · doi:10.1038/srep38646 · Cited by 100
Nuclear Factor (Erythroid-Derived 2)-Like 2 Regulates Drug Resistance in Pancreatic Cancer Cells
Hong, Y. B., Kang, H. J., Kwon, S. Y., Kim, H. J., Kwon, K. Y., Cho, C. H., Lee, J., Kallakury, B., & Bae, I. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181c31314 · Cited by 99
Phytochemicals modulate carcinogenic signaling pathways in breast and hormone-related cancers
Cojocneanu, R., Braicu, C., Ráduly, L., Dragoş, N., Dumitrascu, D. L., Berindan‐Neagoe, I., Zănoagă, O., & Monroig-Bosque, P. D. C. (2015) · OncoTargets and Therapy · doi:10.2147/ott.s83597 · Cited by 98
Self-citationEpigenetic DNA Methylation of Antioxidative Stress Regulator NRF2 in Human Prostate Cancer
Khor, T. O., Fuentes, F., Shu, L., Paredes‐Gonzalez, X., Yang, Y., Liu, Y., Smiraglia, D. J., Yegnasubramanian, S., Nelson, W. G., & Kong, A. T. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0127 · Cited by 94
Fabrizio, F. P., Costantini, M., Copetti, M., la Torre, A., Sparaneo, A., Fontana, A., Poeta, M. L., Gallucci, M., Sentinelli, S., Graziano, P., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14492 · Cited by 92
Nrf2, but not β‐catenin, mutation represents an early event in rat hepatocarcinogenesis
Zavattari, P., Perra, A., Menegon, S., Kowalik, M. A., Petrelli, A., Angioni, M. M., Follenzi, A., Quagliata, L., Ledda‐Columbano, G. M., Terracciano, L., et al. (2015) · Hepatology · doi:10.1002/hep.27790 · Cited by 91
The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer
Hayden, A. L., Douglas, J., Sommerlad, M., Andrews, L. P., Gould, K., Hussain, S. A., Thomas, G. J., Packham, G., & Crabb, S. J. (2014) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2014.02.006 · Cited by 91
Shi, L., Chen, Z., Wu, L., Zheng, J., Yang, J., Chen, X., Chen, Z.-Q., Cun-li, L., Chi, S.-Y., Zheng, J., et al. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.23.10439 · Cited by 91
Web-based molecular graphics for large complexes
Rose, A., Bradley, A. R., Valasatava, Y., Duarte, J. M., Prlić, A., & Rose, P. W. (2016) · international conference on 3D web technology · doi:10.1145/2945292.2945324 · Cited by 91
NRF2 facilitates breast cancer cell growth via HIF1ɑ-mediated metabolic reprogramming
Zhang, H., Du, G.-Y., Zhang, Z.-G., Zhou, Z., Sun, H., Yu, X., Shi, Y., Xiong, D.-N., Li, H., & Huang, Y. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.12.016 · Cited by 86
A novel Nrf2-miR-29-desmocollin-2 axis regulates desmosome function in keratinocytes
Kurinna, S. M., Schäfer, M., Ostano, P., Karouzakis, E., Chiorino, G., Bloch, W., Bachmann, A., Gay, S., Garrod, D. R., Lefort, K., et al. (2014) · Nature Communications · doi:10.1038/ncomms6099 · Cited by 85
NRF2 immunolocalization in human breast cancer patients as a prognostic factor
Onodera, Y., Motohashi, H., Takagi, K., Miki, Y., Shibahara, Y., Watanabe, M., Ishida, T., Hirakawa, H., Sasano, H., Yamamoto, M., et al. (2014) · Endocrine-Related Cancer · doi:10.1530/erc-13-0234 · Cited by 81 · cited 1×
“Increase as the disease progresses, leads to poor prognostic (p62) [83]”
BackgroundNrf2: bane or blessing in cancer?
Xiang, M., Namani, A., Wu, S., & Wang, X. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1627-1 · Cited by 77
MafK positively regulates NF-κB activity by enhancing CBP-mediated p65 acetylation
Hwang, Y.-J., Lee, E., Song, J., Kim, H.-R., Jun, Y.-C., & Hwang, K. (2013) · Scientific Reports · doi:10.1038/srep03242 · Cited by 76
Nrf2 overexpression is associated with P-glycoprotein upregulation in gastric cancer
Jeddi, F., Soozangar, N., Sadeghi, M. R., Somi, M. H., Shirmohamadi, M., Eftekhar-Sadat, A.-T., & Samadi, N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.10.129 · Cited by 75
E-cadherin inhibits nuclear accumulation of Nrf2: implications for chemoresistance of cancer cells
Kim, W., Kim, Y. W., Cho, I. J., Lee, C. H., & Kim, S. G. (2012) · Journal of Cell Science · doi:10.1242/jcs.095422 · Cited by 72
Shah, N., Zaitseva, L., Bowles, K. M., MacEwan, D. J., & Rushworth, S. A. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.152 · Cited by 70
Choi, B.-H., Ryoo, I.-G., Kang, H. C., & Kwak, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107158 · Cited by 70
The Role of Nrf2 in Migration and Invasion of Human Glioma Cell U251
Pan, H., Wang, H., Zhu, L., Mao, L., Qiao, L., & Su, X. (2011) · World Neurosurgery · doi:10.1016/j.wneu.2011.06.063 · Cited by 68
Involvement of NRF2 Signaling in Doxorubicin Resistance of Cancer Stem Cell-Enriched Colonospheres
Ryoo, I.-G., Kim, G., Choi, B.-H., Lee, S.-H., & Kwak, M. (2016) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2016.145 · Cited by 67
Nanopharmacology in translational hematology and oncology
Berindan‐Neagoe, I., Braicu, C., Craciun, L., Irimie, A. I., & Takahashi, Y. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s60488 · Cited by 66
Self-citationKang, H. J., Yi, Y. W., Hong, Y. B., Kim, H. J., Jang, Y., Seong, Y., & Bae, I. (2014) · Scientific Reports · doi:10.1038/srep07201 · Cited by 66
Understanding the role of NRF2-regulated miRNAs in human malignancies
Shah, N., Rushworth, S. A., Murray, M. Y., Bowles, K. M., & MacEwan, D. J. (2013) · Oncotarget · doi:10.18632/oncotarget.1181 · Cited by 66
Jia, Y., Chen, J., Zhu, H., Jia, Z., & Cui, M. (2015) · Oncology Reports · doi:10.3892/or.2015.4214 · Cited by 66
Functional Role of NRF2 in Cervical Carcinogenesis
Ma, J., Hatila, T., Jiao, S.-J., Jian-He, Z., Jing-Bao, X., & Hasim, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133876 · Cited by 65
WNT-3A Regulates an Axin1/NRF2 Complex That Regulates Antioxidant Metabolism in Hepatocytes
Rada, P., Rojo, A. I., Offergeld, A., Feng, G. J., Velasco-Martin, J. P., González‐Sancho, J. M., Valverde, Á. M., Dale, T. C., Regadera, J., & Cuadrado, A. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6040 · Cited by 65
p38 MAPK-dependent Nrf2 induction enhances the resistance of glioma cells against TMZ
Ma, L., Liu, J., Zhang, X., et al. (2015) · Medical Oncology · doi:10.1007/s12032-015-0517-y · Cited by 65
NCRNA Combined Therapy as Future Treatment Option for Cancer
Braicu, C., Cătană, C.-S., Călin, G. A., & Berindan‐Neagoe, I. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140826153529 · Cited by 64
Self-citationmiR-432 Induces NRF2 Stabilization by Directly Targeting KEAP1
Akdemir, B., Nakajima, Y., Inazawa, J., & Inoue, J. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0232 · Cited by 63
Shukla, K., Sonowal, H., Saxena, A., Ramana, K. V., & Sk, S. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.09.031 · Cited by 63
miRNA Influences in NRF2 Pathway Interactions within Cancer Models
Ayers, D., Baron, B., & Hunter, T. (2015) · Journal of Nucleic Acids · doi:10.1155/2015/143636 · Cited by 62
Non‐coding RNAs as theranostics in human cancers
Redis, R. S., Berindan‐Neagoe, I., Pop, V. I., & Călin, G. A. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24038 · Cited by 62
Self-citationKawasaki, Y., Ishigami, S., Arigami, T., Uenosono, Y., Yanagita, S., Uchikado, Y., Kita, Y., Nishizono, Y., Okumura, H., Nakajo, A., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1008-4 · Cited by 62
Jung, K.-A., Lee, S., & Kwak, M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6797 · Cited by 62
Braicu, C., Pileczki, V., Irimie, A., & Berindan‐Neagoe, I. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1688-5 · Cited by 61
Self-citationNrf2 Orchestrates Fuel Partitioning for Cell Proliferation
Hayes, J. D., & Ashford, M. L. J. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.009 · Cited by 60
Khan, A. U. H., Rathore, M. G., Allende-Vega, N., Vo, D.-N., Belkhala, S., Orecchioni, S., Talarico, G., Bertolini, F., Cartron, G., Lecellier, C.-H., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2015.11.045 · Cited by 59
Chen, C., Jiang, X., Gu, S., & Zhang, Z. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.07.215 · Cited by 59
NRF2-regulated metabolic gene signature as a prognostic biomarker in non-small cell lung cancer
Namani, A., Cui, Q., Wu, Y., Wang, H., Wang, X. J., & Tang, X. (2017) · Oncotarget · doi:10.18632/oncotarget.19349 · Cited by 56
Opportunities and challenges provided by crosstalk between signalling pathways in cancer
Prahallad, A., & Bernards, R. (2015) · Oncogene · doi:10.1038/onc.2015.151 · Cited by 54
IL-11 contribution to tumorigenesis in an NRF2 addiction cancer model
Kitamura, H., Onodera, Y., Murakami, S., Suzuki, T., & Motohashi, H. (2017) · Oncogene · doi:10.1038/onc.2017.236 · Cited by 54
Tertil, M., Gołda, S., Skrzypek, K., Florczyk, U., Węglarczyk, K., Kotlinowski, J., Maleszewska, M., Czauderna, S., Pichon, C., Kiéda, C., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.08.004 · Cited by 51
Cheung, K. L., Lee, J. H., Shu, L., Kim, J. H., Sacks, D. B., & Kong, A. T. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.444182 · Cited by 51
Lim, J., Lee, S. H., Cho, S., Lee, I., Kang, B. Y., & Choi, H. J. (2013) · Molecules and Cells · doi:10.1007/s10059-013-0123-9 · Cited by 49
Zhang, C., Shu, L., & Kong, A. T. (2015) · Current Pharmacology Reports · doi:10.1007/s40495-014-0013-7 · Cited by 49
Activation of AKT pathway by Nrf2/PDGFA feedback loop contributes to HCC progression
Liu, D., Zhang, Y., Wei, Y., Liu, G., Liu, Y., Gao, Q., Zou, L., Zeng, W., & Zhang, N. (2016) · Oncotarget · doi:10.18632/oncotarget.11700 · Cited by 47
Pun, N. T., & Park, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-00456-6 · Cited by 47
CO/HO-1 Induces NQO-1 Expression via Nrf2 Activation
Kim, H. J., Zheng, M., Kim, S., Cho, J. J., Shin, C. H., Joe, Y., & Chung, H. (2011) · Immune Network · doi:10.4110/in.2011.11.6.376 · Cited by 46
Association between Smoking and p53 Mutation in Lung Cancer: A Meta-analysis
Liu, X., Lin, X. J., Wang, C. P., Yan, K. K., Zhao, L., AN, W. X., & Liu, X. (2013) · Clinical Oncology · doi:10.1016/j.clon.2013.09.003 · Cited by 46
Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery
Aldea, M. D., Craciun, L., Tomuleasa, C., Berindan‐Neagoe, I., Kacsó, G., Florian, I. Ş., & Crivii, C. B. (2014) · Tumor Biology · doi:10.1007/s13277-014-1676-8 · Cited by 44
Self-citationNRF2/miR-140 signaling confers radioprotection to human lung fibroblasts
Duru, N., Gernapudi, R., Zhang, Y., Yao, Y., Lo, P., Wolfson, B., & Zhou, Q. Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.08.011 · Cited by 41
Cong, Z., wang, H.-D., Zhou, Y., Wang, J., Pan, H., Zhang, D.-D., Zhang, L., & Zhu, L. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1260-x · Cited by 40
Targeting Signalling Pathways in Hepatocellular Carcinoma
Cokan, K. B., & Rozman, D. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666161006160005 · Cited by 39
Cardinal‐Fernández, P., Ferruelo, A., Esteban, A., & Lorente, J. A. (2015) · Translational research · doi:10.1016/j.trsl.2015.11.004 · Cited by 38
Liu, M., Hu, C., Xu, Q., Chen, L., Ma, K., Xu, N., & Zhu, H. (2015) · Bioscience Reports · doi:10.1042/bsr20150092 · Cited by 37
High NRF2 expression controls endoplasmic reticulum stress induced apoptosis in multiple myeloma
Sun, Y., Aziz, A., Bowles, K. M., & Rushworth, S. A. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.10.005 · Cited by 34
Kozakowska, M., Dobrowolska-Glazar, B., Okoń, K., Józkowicz, A., Dobrowolski, Z. F., & Dulak, J. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5030029 · Cited by 29
Li, C., Wu, H.-T., Wang, S., & Zhu, J. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5913 · Cited by 29
Nrf2 sensitizes prostate cancer cells to radiation via decreasing basal ROS levels
Liu, M., Yao, X., Li, W., Geng, J., Yan, Y., Che, J., Xu, Y., & Zheng, J. (2015) · BioFactors · doi:10.1002/biof.1200 · Cited by 27
Chen, X., Guan, H., Liu, X., Xie, D., Wang, Y., Ma, T., Huang, B., & Zhou, P. (2018) · Oncology Letters · doi:10.3892/ol.2018.8619 · Cited by 27
Potteti, H. R., Tamatam, C. R., Marreddy, R., Reddy, N. M., Noel, S., Rabb, H., & Reddy, S. P. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00362.2016 · Cited by 26
Sun, X., Liu, D., Xue, Y., & Hu, X. (2017) · Clinical Laboratory · doi:10.7754/clin.lab.2016.161116 · Cited by 26
Karihtala, P., Porvari, K., Soini, Y., & Haapasaari, K. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2696071 · Cited by 24
Liu, Q., Zhang, J., Liu, X., & Gao, J. (2015) · Cell Proliferation · doi:10.1111/cpr.12206 · Cited by 22
Marts, L. T., Green, D. E., Mills, S. T., Murphy, T., & Sueblinvong, V. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13496 · Cited by 21
Genrich, G., Kruppa, M., Lenk, L., Helm, O., Broich, A., Freitag‐Wolf, S., Röcken, C., Sipos, B., Schäfer, H., & Sebens, S. (2016) · BMC Cancer · doi:10.1186/s12885-016-2191-7 · Cited by 20
Tian, S., Yong, M., Zhu, J., Zhang, L., Li, P., Chen, Q., Li, K., Kong, Y., Jiang, Y., Yu, T., et al. (2017) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520617666170327145857 · Cited by 20
Yoshino, H., Murakami, K., Nawamaki, M., & Kashiwakura, I. (2018) · Biomedical Reports · doi:10.3892/br.2018.1073 · Cited by 8
Cited by
Zafar, A., Khatoon, S., Khan, M. J., Abu, J., & Naeem, A. (2025) · Discover Oncology · doi:10.1007/s12672-025-02198-8 · Cited by 565
Afzal, S., Abdul Manap, A. S., Attiq, A., Albokhadaim, I., Kandeel, M., & Alhojaily, S. M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1269581 · Cited by 416
Cancer Metabolism: The Role of ROS in DNA Damage and Induction of Apoptosis in Cancer Cells
Zhao, Y., Ye, X., Xiong, Z., Ihsan, A., Ares, I., Martínez, M., Lopez-Torres, B., Martínez-Larrañaga, M.-R., Anadón, A., Wang, X., et al. (2023) · Metabolites · doi:10.3390/metabo13070796 · Cited by 323
Oxidative Stress in the Tumor Microenvironment and Its Relevance to Cancer Immunotherapy
Aboelella, N. S., Brandle, C., Kim, T., Ding, Z.-C., & Zhou, G. (2021) · Cancers · doi:10.3390/cancers13050986 · Cited by 286
Cui Zhou, D., Jayasinghe, R. G., Chen, S., Herndon, J. M., Iglesia, M. D., Navale, P., Wendl, M. C., Caravan, W., Sato, K., Storrs, E., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01157-1 · Cited by 284
Metadata
- Authors
- Zimta, A.-A., Cenariu, D., Irimie, A., Magdo, L., Nabavi, S. M., Atanasov, A. G., & Berindan-Neagoe, I.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2019-11-08
- Volume
- 11
- Issue
- 11
- Pages
- 1755
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W2986456455
- Cited by
- 292
- References
- 158
- FWCI
- 8.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.